Amedisys (NASDAQ:AMED) Given “Equal Weight” Rating at Stephens

Amedisys (NASDAQ:AMED)‘s stock had its “equal weight” rating reaffirmed by equities research analysts at Stephens in a research report issued on Tuesday,Benzinga reports. They presently have a $101.00 price objective on the health services provider’s stock. Stephens’ price target would indicate a potential upside of 9.75% from the company’s previous close.

Amedisys Price Performance

Amedisys stock opened at $92.03 on Tuesday. Amedisys has a 52 week low of $82.15 and a 52 week high of $98.95. The company’s 50 day moving average price is $91.69 and its two-hundred day moving average price is $93.06. The stock has a market cap of $3.01 billion, a P/E ratio of 36.52, a P/E/G ratio of 1.78 and a beta of 0.73. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported $0.96 EPS for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.09). The business had revenue of $598.05 million for the quarter, compared to the consensus estimate of $602.38 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. On average, equities analysts predict that Amedisys will post 4.4 earnings per share for the current year.

Institutional Investors Weigh In On Amedisys

Large investors have recently modified their holdings of the stock. Blue Trust Inc. lifted its stake in Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 124 shares during the last quarter. HBW Advisory Services LLC bought a new stake in shares of Amedisys in the fourth quarter valued at $38,000. Versant Capital Management Inc raised its stake in shares of Amedisys by 68.5% in the fourth quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock valued at $41,000 after buying an additional 183 shares during the period. Johnson Financial Group Inc. purchased a new position in shares of Amedisys during the 4th quarter valued at $55,000. Finally, KBC Group NV bought a new position in shares of Amedisys during the 3rd quarter worth $63,000. Hedge funds and other institutional investors own 94.36% of the company’s stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.